V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16627456 | 330006988 | EN201 | 1500 | X724 | 1 | 2015-09-05 | FLUOROURACIL | 330007251 | 330003770 | 330006990 |
| 16627457 | 330006988 | ERA20 | 1800 | X724 | 1 | 2015-09-05 | FLUOROURACIL | 330007251 | 330003770 | 330006990 |
| 16627458 | 330006988 | ENW | 20 | X721 | 2 | 2015-09-05 | NOT CHEMO | 330007251 | 330003770 | 330006990 |
| 16627459 | 330006989 | EEI00 | 50 | null | 1 | 2015-05-29 | CYTARABINE | 330007251 | 330008035 | 330006991 |
| 16627460 | 330006991 | EEI00 | 3000 | null | 1 | 2015-02-07 | BEVACIZUMAB | 330007251 | 330008035 | 330006993 |
| 16627461 | 330006991 | EE813 | 150 | X292 | 1 | 2015-02-07 | BMS-986016 | 330007251 | 330008035 | 330006993 |
| 16627462 | 330006992 | EEI00 | null | x724 | 1 | 2017-03-19 | IFOSFAMIDE | 330007260 | 330003772 | 330006994 |
| 16627463 | 330006992 | EEI00 | 1.05 | X724 | 1 | 2017-03-20 | TOPOTECAN | 330007260 | 330003772 | 330006994 |
| 16627464 | 330006992 | EJRNN | 1800 | null | 1 | 2017-03-21 | MESNA | 330007260 | 330003772 | 330006994 |
| 16627465 | 330006992 | EJR | 5600 | null | 1 | 2017-03-21 | AVELUMAB | 330007260 | 330003772 | 330006994 |
| 16627466 | 330006994 | EEI00 | 8 | X729 | 1 | 2015-06-26 | ETOPOSIDE | 330007290 | 330010360 | 330006996 |
| 16627467 | 330006994 | EGU08 | 100 | null | 1 | 2015-06-26 | ETOPOSIDE | 330007290 | 330010360 | 330006996 |
| 16627468 | 330006994 | EEI00 | 0.5 | null | 1 | 2015-06-27 | FLUDARABINE | 330007290 | 330010360 | 330006996 |
| 16627469 | 330006994 | Haqrsvarq | 36 | X729 | 1 | 2015-06-27 | CISPLATIN | 330007290 | 330010360 | 330006996 |
| 16627470 | 330006994 | ECL02 | 23 | null | 1 | 2015-06-28 | MESNA | 330007290 | 330010360 | 330006996 |
| 16627471 | 330006994 | Haqrsvarq | 1100 | null | 1 | 2015-06-28 | FLUOROURACIL | 330007290 | 330010360 | 330006996 |
| 16627472 | 330006994 | EE813 | 132 | X721 | 1 | 2015-06-28 | DOCETAXEL | 330007290 | 330010360 | 330006996 |
| 16627473 | 330006995 | EK1EN | 8 | null | 1 | 2016-05-11 | ETOPOSIDE | 330007290 | 330003776 | 330006997 |
| 16627474 | 330006995 | EZ102 | 50 | null | 1 | 2016-05-11 | ETOPOSIDE | 330007290 | 330003776 | 330006997 |
| 16627475 | 330006995 | EJR | 3800 | null | 1 | 2016-05-11 | IFOSFAMIDE | 330007290 | 330003776 | 330006997 |
| 16627476 | 330006995 | EEI00 | 5.6 | X721 | 1 | 2016-05-12 | IFOSFAMIDE | 330007290 | 330003776 | 330006997 |
| 16627477 | 330006995 | EEI00 | 3000 | X721 | 1 | 2016-05-13 | IFOSFAMIDE | 330007290 | 330003776 | 330006997 |
| 16627478 | 330006995 | EN201 | 1200 | null | 1 | 2016-05-13 | FLUOROURACIL | 330007290 | 330003776 | 330006997 |
| 16627479 | 330006995 | ERA20 | 0.9 | X724 | 1 | 2016-05-13 | CISPLATIN | 330007290 | 330003776 | 330006997 |
| 16627480 | 330006995 | EEI00 | 4 | X724 | 1 | 2016-05-13 | NOT CHEMO | 330007290 | 330003776 | 330006997 |
| 16627481 | 330006996 | ECL01 | 4800 | null | 1 | 2015-09-02 | METHOTREXATE | 330007308 | 330008039 | 330006998 |
| 16627482 | 330006996 | E0N03 | 200 | X724 | 1 | 2015-09-02 | NIVOLUMAB | 330007308 | 330008039 | 330006998 |
| 16627483 | 330006996 | EC4 | 55 | X729 | 2 | 2015-09-02 | TRIAL | 330007308 | 330008039 | 330006998 |
| 16627484 | 330006997 | EEI00 | 175 | null | 1 | 2015-04-25 | ETOPOSIDE | 330007308 | 330008039 | 330006999 |
| 16627485 | 330006997 | ERA20 | 100 | null | 1 | 2015-04-25 | NOT CHEMO | 330007308 | 330008039 | 330006999 |
| 16627486 | 330006997 | EUZ01 | 1450 | X724 | 1 | 2015-04-25 | TOPOTECAN | 330007308 | 330008039 | 330006999 |
| 16627487 | 330006997 | ECL02 | 1.5 | null | 1 | 2015-04-25 | DOCETAXEL | 330007308 | 330008039 | 330006999 |
| 16627488 | 330006997 | ED301 | 140 | X721 | 1 | 2015-04-25 | DACTINOMYCIN | 330007308 | 330008039 | 330006999 |
| 16627489 | 330006997 | EN201 | 1500 | X721 | 1 | 2015-04-25 | FLUOROURACIL | 330007308 | 330008039 | 330006999 |
| 16627490 | 330006997 | EN201 | 97 | X724 | 1 | 2015-04-26 | CISPLATIN | 330007308 | 330008039 | 330006999 |
| 16627491 | 330006997 | E1UZ0 | 4 | null | 2 | 2015-04-26 | STEROID | 330007308 | 330008039 | 330006999 |
| 16627492 | 330006998 | EUJ01 | 1.15 | null | 1 | 2018-12-27 | VINCRISTINE | 330007315 | 330003780 | 330007000 |
| 16627493 | 330006998 | ED301 | 100 | x724 | 1 | 2018-12-27 | CETUXIMAB | 330007315 | 330003780 | 330007000 |
| 16627494 | 330006998 | EEI00 | 170 | null | 1 | 2018-12-27 | DOCETAXEL | 330007315 | 330003780 | 330007000 |
| 16627495 | 330006998 | EE813 | 1800 | null | 1 | 2018-12-27 | NOT CHEMO | 330007315 | 330003780 | 330007000 |
| 16627496 | 330006998 | EEI00 | 0 | X729 | 1 | 2018-12-27 | DOXORUBICIN | 330007315 | 330003780 | 330007000 |
| 16627497 | 330006998 | EE813 | 148 | X724 | 1 | 2018-12-27 | DOCETAXEL | 330007315 | 330003780 | 330007000 |
| 16627498 | 330006998 | ERA20 | 113 | X721 | 1 | 2018-12-27 | CISPLATIN | 330007315 | 330003780 | 330007000 |
| 16627499 | 330006998 | EOI | 8 | null | 1 | 2018-12-28 | NOT CHEMO | 330007315 | 330003780 | 330007000 |
| 16627500 | 330006999 | Haqrsvarq | 200 | null | null | 2017-12-23 | VINCRISTINE | 330007315 | 330003780 | 330007001 |
| 16627501 | 330006999 | EK1EN | 4800 | X729 | 1 | 2017-12-23 | TOPOTECAN | 330007315 | 330003780 | 330007001 |
| 16627502 | 330007000 | EE813 | 1.15 | X724 | 1 | 2014-12-17 | IFOSFAMIDE | 330007321 | 330003782 | 330007002 |
| 16627503 | 330007000 | ERS12 | 160 | null | 1 | 2014-12-18 | DOXORUBICIN | 330007321 | 330003782 | 330007002 |
| 16627504 | 330007000 | EEI00 | 170 | null | 1 | 2014-12-18 | VINCRISTINE | 330007321 | 330003782 | 330007002 |
| 16627505 | 330007000 | E1UZ0 | 1.5 | X292 | 1 | 2014-12-18 | CARBOPLATIN | 330007321 | 330003782 | 330007002 |